Can patients with asymptomatic SARS-CoV-2 infection safely undergo elective surgery?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35369990.
- Also identified by DOI 10.1016/j.bja.2022.03.003 and PMC identifier 8907026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Current or recent infection with SARS-CoV-2 increases the risk of perioperative morbidity and mortality. Consensus guidelines recommend delaying elective major surgery after acute SARS-CoV-2 infection for 7 or 8 weeks. However, because of the growing backlog of untreated surgical disease and the potential risks of delaying surgery, surgical services may be under pressure to reduce this period. Here, we discuss the risks and benefits of delaying surgery for patients with current or recent SARS-CoV-2 infection in the context of the evolving COVID-19 pandemic, the limited evidence supporting delays to surgery, and the need for more research in this area.
Medical subject headings
- COVID-19